Findings of various clinical trials and observational studies conflict over the risk of malignancy related to the use of tumor necrosis factor alpha (TNFa) blockers, a biologic therapy shown ...

Some treatments show potential for wider application. Biologic therapies are helping advance severe asthma management by ...

Nearly 4 million patients with chronic obstructive pulmonary disease (COPD) or asthma die each year, mostly from severe acute ...

The absolute number of new biologic drug approvals in any given ... of an application for the drug's approval as an osteoporosis treatment by July 25. But there are no XenoMouse-derived antibodies ...

In recent years, the evolution of biologic therapies for severe asthma has paralleled advancements in other chronic ...

Biologic medications are drugs made from living things. They are considered cutting-edge treatments for a variety of conditions, but they can also cause some side effects. Talk with your doctor ...

YESINTEK works by targeting specific proteins that contribute to inflammation, offering a new treatment option for patients ...

In asthma, as in autoimmune diseases, biologics targeting cytokine pathways such as interleukin (IL)-4, IL-5, and anti-thymic stromal lymphopoietin enable clinicians to tailor treatments to ...

Early implementation of treatment with biologic or targeted synthetic DMARDs after methotrexate failure did not prevent the ...

Mirikizumab (Omvoh) improved outcomes in patients with moderately-to-severely active Crohn's disease with previous failure to ...

Colorectal cancer (CRC) is a leading tumor worldwide. In CRC, the angiogenic pathway plays a crucial role in cancer ...